SKU:K1351 | M. Wt:289.28 | ||
Formula:C14H8FNO3S | Solubility:No | ||
Purity:>99% | Storage:2 years at -20 degrees centigrade | ||
CAS No.:1218777-13-9 | Synonyms:N/A | ||
Chemical NameN/A |
供货周期: | 一周 |
品牌: | |
规格: | 10mg |
货号: | K1351 |
CAS号: | 1218777-13-9 |
SKU:K1351 | M. Wt:289.28 | ||
Formula:C14H8FNO3S | Solubility:No | ||
Purity:>99% | Storage:2 years at -20 degrees centigrade | ||
CAS No.:1218777-13-9 | Synonyms:N/A | ||
Chemical NameN/A |
Description | CAY10505 | |||||
---|---|---|---|---|---|---|
Targets | PI3K-gamma | |||||
IC50 | 33 nM | |||||
In vitro | CAY10505 can inhibit PI3K-gamma with IC50 of 33 nM. | |||||
In vivo | Five weeks of DOCA administration were followed by 7 days of daily administration of PI3K-gamma inhibitor (5-[[5-(4-fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione (CAY10505), 0.6 mg.kg(-1), per os (p.o.)), atorvastatin (30 mg.kg(-1), p.o.), and losartan (25 mg.kg(-1), p.o.) (positive control of hypertension), which significantly improved acetylcholine-induced endothelium dependent relaxation, serum nitrate and (or) nitrite level, glutathione level, and the vascular endothelial lining in hypertensive rats. | |||||
Clinical Trials | N/A | |||||
Features | N/A |
相关产品
重组人肌球蛋白轻链2(Recombinant Human MYL2)
重组大鼠抵抗素(Rat Resistin)
大鼠酸性磷酸酶(ACP)ELISA Kit
大鼠胆囊收缩素/缩胆囊素八肽(CCK-8)ELISA Kit
人瘦素(LEP)ELISA Kit
重组人半乳糖凝集素16/LGALS16 Human
重组人半乳糖凝集素8/Human LGALS8 His
重组人半乳糖凝集素3/Human LGALS3 His
重组人卵泡抑素/Human FST His
重组人β防御素118/DEFB118 Human
重组人心肌营养素1/CTF1 Human
特级新生牛血清(无支原体)
超级新生牛血清(无支原体)
优级胎牛血清(无支原体)
特级新生牛血清(无噬菌体低内毒素)
详细地址
关注
拨打电话
留言咨询